Teleflex Incorporated To Focus On Showcasing Its Intraosseous And Central Vascular Access Portfolio Featuring chlorhexidine Based Technologies At GAVeCeLT 2015 – December 1-3, In Milan, Italy

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, is committed to connecting clinicians with technology in a way that improves clinical practice and advances patient outcomes. Teleflex will attend the GAVeCeLT conference in Milan, Italy on December 1-3, 2015.